A change from group housing to isolation in unfamiliar metabolic cages represents, for rodents, a significant emotional stress. We studied the effect of candesartan, a peripheral and central angiotensin II AT 1 -receptor antagonist, on the hormonal and sympathetic response to acute isolation. We pretreated rats with 1 mg/kg/day candesartan for 13 days via subcutaneously implanted osmotic minipumps, followed by 24-hour isolation in individual metabolic cages. We measured brain, pituitary and adrenal angiotensin II (Ang II) receptor binding by quantitative autoradiography and adrenal hormones and catecholamines by RIA and HPLC. Isolation increased adrenal catecholamines, aldosterone and corticosterone, AT 1 -receptor binding in the zona glomerulosa and AT 2 -receptor binding in the adrenal medulla. Candesartan pretreatment decreased adrenal catecholamines, aldosterone and corticosterone, AT 1 -receptor binding in adrenal zona glomerulosa and medulla, pituitary gland and the hypothalamic paraventricular nucleus, and AT 2 -receptor binding in adrenal medulla, but increased AT 2 -receptor binding in zona glomerulosa. We conclude that peripheral and central AT 1 -receptor blockade with candesartan decreases the sympatho-adrenal and hormonal response to acute stress. Our results indicate that Ang II is an important stress hormone and suggest that blockade of the physiologically active AT 1 -receptors could influence stress-related disorders.
Introduction
In addition to its role in the regulation of blood pressure, fluid and electrolyte homeostasis, angiotensin II (Ang II) is implicated in the response of the hypothalamic-pituitary-adrenal axis to stress. [1] [2] [3] Circulating Ang II and the expression of Ang II receptors in brain areas such as the hypothalamic paraventricular nucleus (PVN) are increased during stress. 2, [4] [5] [6] [7] During stress, Ang II stimulates CRH formation in the PVN, leading to increased ACTH release from the pituitary gland and increased adrenal corticoids. 5, 6, [8] [9] [10] In turn, increased adrenal corticoids regulate the expression of Ang II receptors in the PVN. 5, 6 In addition, Ang II has direct effects on adrenal function, stimulating aldosterone secretion from the zona glomerulosa and catecholamine release from the medulla. 11, 12 There are, in mammals, two types of Ang II binding sites, corresponding to the AT 1 -and AT 2receptors. These receptor types have been cloned and characterised pharmacologically. 13, 14 The AT 1 site is the physiologically active Ang II receptor, mediating most, if not all, of the well-known functions of Ang II 14, 15 and is the receptor subtype proposed to mediate the role of Ang II in the regulation of the response to restraint stress. 2 The AT 2 site is highly expressed in peripheral foetal tissues, in the immature brain, and in the rodent adrenal medulla and zona glomerulosa. 3, [16] [17] [18] [19] This site has been proposed to be involved in the regulation of growth, and to cross-talk with the AT 1 -receptor. 3, 20 However, the experimental evidence is equivocal, and its physiological function has not yet been determined. 3, 21 To further clarify the role of Ang II, we examined the role of AT 1 -and AT 2 -receptors during a clinically relevant form of stress, that of isolation in unfamiliar surroundings. We asked the question whether pretreatment with an Ang II AT 1 -receptor antagonist, administered peripherally, could modulate the hormonal and sympatho-adrenal response to isolation. in their cages in groups of six under standard conditions for 13 days. On day 13, two groups of six animals each (untreated or candesartan-treated) were individually housed in standard, 50 in 2 , plastic metabolic cages (Nalgene, Rochester NY) that were located in the same animal room. Regular rat food and water were provided ad libitum throughout the experiment. At the end of the experiment, on day 14, the animals were sacrificed by decapitation and the adrenal glands, pituitaries and brains were removed, frozen in isopentane at -30°C on dry ice, and stored at -80°C until used. Adrenal glands were homogenised in 0.3 N perchloric acid for determination of catecholamines, aldosterone and corticosterone. The clear supernatant obtained after centrifugation was stored frozen until assay.
Tissue hormone determinations were performed in grouped,non-stressed rats,and the results compared with those found in isolated rats treated with the AT 1 -antagonist or with vehicle. Thus, comparisons were made between tissue levels of catecholamines and/or hormones in isolated vs. grouped animals, and of the effects of AT 1 -receptor blockade during isolation. Adrenal hormones were determined by radioimmunoassay using commercially available kits from ICN Biomedicals, Inc., Costa Mesa, CA for aldosterone and corticosterone. Catecholamines in aliquots of adrenal supernatants were determined by reverse-phase high-pressure liquid chromatography (HPLC) with electrochemical detection. 22
Autoradiography of angiotensin II receptor subtypes
Consecutive coronal brain sections, 8 µm-thick, and consecutive sections from pituitary gland and adrenal gland, 16 µm-thick, were cut in a cryostat and thaw-mounted on gelatinised slides, dehydrated overnight in a desiccator at 4°C, and kept at -80°C until used. Binding experiments were performed as described earlier. 23 Sections were preincubated for 15 minutes in 10 mM sodium phosphate buffer, pH 7.4, containing 120 mM NaCl, 5 mM EDTA, 0.005% bacitracin and 0.2% bovine serum albumin. After preincubation, slides were transferred to fresh buffer containing 0.5 nM [ 125 I] Sar 1 -Ang II (Peninsula Laboratories Inc. Belmont, CA), iodinated by New England Nuclear (Boston, MA) to a specific activity of 2200 Ci/mmol to determine total binding. Non-specific binding was determined by incubation of consecutive sections as above in the presence of 5 µM unlabelled Ang II. The binding of [ 125 I] Sar 1 -Ang II to AT 1 -receptors was determined in consecutive sections incubated with 0.5 nM [ 125 I] Sar 1 -Ang II in the presence of 10 µM of the AT 1 -receptor antagonist losartan (DuPont Merck, Wilmington, DE). Losartan has been shown previously to completely displace binding from AT 1 -receptors at this concentration. 23 AT 1 -receptor binding was the binding selectively displaced by losartan in our experiments. The binding of [ 125 I] Sar 1 -Ang II to AT 2 -receptors was determined in consecutive sections incubated with 0.5 nM of [ 125 I] Sar 1 -Ang II in the presence of 1 µM of the selective AT 2 ligand PD 123319 (Parke Davis, Ann Arbor, MI). PD 123319 has previously been shown to completely displace binding from AT 2receptors at this concentration. 23 AT 2 -receptor binding was the binding selectively displaced by PD 123319 in our experiments.
After incubation for 2 hours at 22°C, sections were washed four times, 1 minute each, in ice-cold 50 mM Tris-HCl buffer pH 7.4, rinsed in ice-cold water, and dried under a stream of cold air. Sections were exposed to Hyperfilm-[3H] (Amersham Corporation, Arlington Heights, IL). Optical densities of autoradiograms were determined by computerised microdensitometry using the Image 1.61 program (NIMH, Bethesda, MD), quantified by comparison with [ 125 I] micro-scales (Amersham Corporation, Arlington Heights, IL) and transformed to corresponding values of fmol/mg protein. 24 Brain regions were identified by comparison with Toluidine Blue staining of consecutive brain sections.
In situ hybridisation of tyrosine hydroxylase mRNA
One antisense (TH-AS) of 48-mer for the rat tyrosine hydroxylase (TH) cDNA sequence localised in nt 1562-1609 25 was synthesised (Lofstrand Labs Limited, MD).
Labelling was performed with a 3'-end labelling kit (Amersham Corporation, Arlington Heights, IL) using terminal deoxynucleotidyl transferase to a specific activity of 3-4 x 10 8 dpm/µg. Each reaction was performed with 70 pmole of oligonucleotides in the presence of 70 µCi of [α- 35 S]ATP (Amersham Corporation, Arlington Heights, IL). The labelled oligonucleotides were separated from unincorporated nucleotides using MicroSpin G-25 columns (Amersham Corporation, Arlington Heights, IL). In situ hybridisation of rat adrenal sections and post-hybridisation washings was performed as described. 26 In situ hybridisation was performed in consecutive adrenal sections incubated with the TH-AS antisense oligonucleotide or with antisense oligonucleotide with addition of excess unlabelled TH-AS probe (157 pmol/ml). After the washing, sections were dehydrated in alcohols containing 0.3 M ammonium acetate, air-dried and exposed to Hyperfilm-3 H (Amersham). The films were developed and quantified as described above by comparison with 14 C standards (American Radiolabeled Chemicals, Inc., St. Louis, MO, USA).
Statistics
Data are presented as means±SEM. One-way ANOVA, followed by post-hoc analysis using the Newman-Keuls multiple comparison test, was used to assess the significance of differences among groups. p<0.05 was considered statistically significant.
Results

Adrenal angiotensin II receptor subtypes
In the zona glomerulosa, isolation stress produced a significant increase in AT 1 -receptor binding ( Figure 1 ). Binding to AT 2 -receptors showed a ten-S131
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March 2001 Volume 2 Supplement 1 S132 dency to increase in the zona glomerulosa after isolation, though the difference did not reach statistical significance (Figure 1 ). In the adrenal medulla, there was no significant change in AT 1receptor binding, but a significant increase in AT 2receptor binding ( Figure 2 ).
Adrenal catecholamines and adrenal hormones
Isolation produced significant elevations in TH mRNA in the adrenal medulla ( Figure 2 ) and signif-icant elevations in adrenal epinephrine (adrenalin) and norepinephrine (noradrenalin) content ( Figure  2 ). After isolation, the adrenal corticosterone content was markedly elevated when compared with those from grouped animals ( Figure 2 ). The adrenal aldosterone content was also increased after isolation when compared with grouped control rats ( Figure 2 ).
Adrenal angiotensin II receptor subtypes
Administration of an AT 1 -antagonist altered the expression of zona glomerulosa Ang II receptor subtype binding in opposite directions. AT 1 -receptor binding was strongly reduced, to amounts much lower than those in control, grouped rats ( Figure 1 ). Conversely, AT 2 -binding in the zona glomerulosa, which was increased by stress, increased even further after treatment with the AT 1 -antagonist ( Figure 1 ). In the adrenal medulla, candesartan decreased AT 1 -binding ( Figure 1 ). The AT 1 -receptor antagonist eliminated the stress-related increase in AT 2binding, reducing AT 2 -binding even further to levels lower than those observed in grouped rats (Figure 1) .
Adrenal catecholamines and adrenal hormones
Blockade of AT 1 -receptors eliminated the increase in TH mRNA as well as the increase in adrenal epinephrine and norepinephrine concentrations produced by isolation, resulting in levels not significantly different from those found in control, grouped rats ( Figure 2 ). AT 1 -receptor blockade normalised the increased corticosterone and aldosterone content produced by isolation in the adrenal gland (Figure 2 ).
Brain and pituitary angiotensin II AT 1 -receptors
The AT 1 -antagonist reduced binding to AT 1 -recep-tors in selected brain areas expressing only AT 1receptors ( Figure 3 ). Decrease in binding (-70%) occurred in the subfornical organ (SFO), from 50±6 to 15±3 fmol/mg protein for controls and candesartan-treated, respectively, and in the PVN (-85%), from 24±3 to 3±0.2 fmol/mg protein, for control and candesartan-treated, respectively. In the anterior pituitary gland, which expresses only AT 1 -receptors, binding was reduced by 79%, from 19±4 to 4±0.7 fmol/mg protein for control and candesartan-treated, respectively (Figure 3 ). No changes in AT 2 -receptor binding were noted after AT 1 -receptor blockade in areas of the brain expressing AT 2 -receptors, such as the inferior olive (results not shown).
Discussion
The role of Ang II has previously been studied during restraint stress. 2 In this study, we selected a more clinically relevant model, that of individual isolation. This represents, for rodents, a significant emotional stress resulting from the restriction from freely regulating their exposure to novel surroundings and their access to familiar territory. 27 A relatively short (24-hour) period of isolation increased adrenal corticosterone, aldosterone, catecholamines and TH mRNA, indicating increased catecholamine and hormone synthesis, in a manner consistent with a classical stress response. Our results are in agreement with previous studies that demon-PAPER Figure 3 Autoradiography of Ang II AT 1 -receptor binding in brain and pituitary gland after pretreatment with candesartan. A: Binding to AT 1 -receptors in brain. Section from a rat treated with vehicle. The section was incubated as described in the text, in the presence of 0.5 nM [ 125 I]Sar 1 -Ang II and 1 µM PD 123319 to reveal binding to AT 1 -receptors. PVN: hypothalamic paraventricular nucleus. SFO: subfornical organ. B: Section from a rat treated with 1.0 mg/kg/day candesartan, for 14 days, as described in text, and incubated as above. Note the marked decrease in AT 1 -binding in the SFO and PVN. C: Section of a pituitary gland, incubated as above to reveal binding to AT 1 -receptors, from a control rat treated with vehicle. D: Section of a pituitary gland, incubated as above, from a rat treated with 1.0 mg/kg/day candesartan, for 14 days, as described in text. Note the marked inhibition of binding to AT 1 -receptors. Bar represents 1 mm.
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March 2001 Volume 2 Supplement 1 S134 PAPER strated that isolation could increase the sensitivity to other forms of stress, as determined by increased epinephrine and corticosterone. 28, 29 Adrenal Ang II receptors were also altered during isolation. Isolation increased AT 1 -receptor binding in the zona glomerulosa and increased AT 2 -receptor binding in the adrenal medulla. Ang II increases aldosterone formation and release through stimulation of AT 1 -receptors in the zona glomerulosa. 30, 31 Thus, the increased number of AT 1 -receptors in the zona glomerulosa correlates with the increased aldosterone concentration, indicative of increased aldosterone synthesis. In the adrenal medulla, increased number of AT 2receptors during isolation correlated with increased adrenomedullary catecholamines. In rat adrenal medulla, AT 1 -receptors, while few in number, mediate catecholamine secretion by Ang II, 32 while the proposed role for AT 2 -receptors in catecholamine release from the adrenal medulla is controversial. 11, 33, 34 Our findings suggest that rat adrenomedullary AT 2 -receptor expression may play a still-undetermined role in catecholamine synthesis and release during isolation.
From the results discussed above, it appeared that during isolation Ang II could participate in the stress response through stimulation of increased numbers of receptors located in the adrenal gland.
We then asked the question whether blockade of the physiological effects of Ang II 3 with an AT 1receptor antagonist could significantly affect the hormonal and sympathoadrenal response to isolation stress. We selected chronic pretreatment with candesartan, a very potent, high affinity, and insurmountable AT 1 -antagonist, before isolation. 35 Predictably, chronic administration of the AT 1 antagonist resulted in a marked decrease in AT 1 binding in the adrenal zona glomerulosa to levels even lower than those in control rats, and this correlated with a significant decrease in adrenal aldosterone to levels not different from those of control, non-stressed rats. These results indicate that increased AT 1 -receptor stimulation in the zona glomerulosa may be an important factor in the increase in aldosterone formation and release during acute isolation stress. In addition, AT 1 blockade increased AT 2 -receptor expression in the zona glomerulosa. This finding is intriguing because AT 2 -receptor stimulation was reported not to be involved in aldosterone synthesis or release. 36 It is possible that alterations in AT 2receptor expression could be related to AT 1 -receptor blockade, and a result of cross-talk between AT 1 -and AT 2 -receptors. 3, 20 The physiological role of the zona glomerulosa AT 2 -receptors, however, remains to be explained.
Candesartan pretreatment profoundly modified the adrenomedullary response to stress, decreasing the expression of adrenal TH mRNA, epinephrine and norepinephrine to levels not different from control grouped rats. These results paralleled the decrease in AT 1 -receptor binding expression in the adrenal medulla. The AT 2 -receptor expression in the adrenal medulla also decreased after AT 1 -blockade, to levels actually lower than those in control grouped rats. The mechanism and significance of these changes has not been clarified, but suggest a still-undetermined role of AT 2 -receptors during isolation stress, and perhaps additional cross-talk between AT 1 -and AT 2 -receptors in the adrenal medulla. 3, 20 We also found that pretreatment with candesartan eliminated the increase in adrenal corticosterone produced by isolation stress. This suggested that AT 1 -receptor blockade could have decreased the production and release of ACTH, characteristic of the stress reaction. Ang II contributes to ACTH release in part through stimulation of AT 1 -receptors in the anterior pituitary. 2, 4 Our finding of complete blockade of pituitary AT 1 -receptors by candesartan indicates that this treatment inhibits corticosterone formation in the adrenal gland, probably by decreasing the release of ACTH during stress. Blockade of ACTH release could also be an additional factor in the decreased adrenal aldosterone during candesartan treatment. 1, 30 We have recently reported that peripheral daily administration of candesartan inhibits AT 1 binding, not only in the periphery but also in the brain, 37 and that receptor blockade occurs to a similar extent in areas outside (SFO) and inside (PVN, nucleus of the solitary tract, NTS) the bloodbrain barrier. This indicates that candesartan readily crosses the blood-brain barrier. 37 We show here, in agreement with our earlier results, that candesartan treatment antagonises not only peripheral, but also brain AT 1 -receptors. Brain AT 1receptors have been implicated in the formation and release of pituitary hormones, in the central control of the sympathoadrenal catecholamines and in the regulation of these systems during stress. 2 AT 1 -receptors regulate the release of ACTH by a central mechanism involving the direct stimulation of CRH formation and release in the parvicellular PVN. 2 Thus, the elimination of the stressinduced increase in adrenal corticosterone by candesartan could be the result of decreased ACTH release produced by a dual mechanism, AT 1 -receptor blockade in the anterior pituitary and decreased CRH formation and release as a consequence of AT 1 -receptor blockade in the PVN. 5, 6, 9 We demonstrate that chronic AT 1 -receptor blockade totally abolished the sympathoadrenal and hormonal response to acute isolation stress, probably as a result of a dual peripheral and central receptor antagonism, indicating that Ang II is a major factor in the stimulation of the hypothalamic-pituitaryadrenal axis during isolation.
It appears that a dual blockade of the peripheral and central AT 1 -receptors may have advantages when compared with selective peripheral or central blockade. Selective central AT 1 -blockade can be achieved by acute administration of AT 1 -antagonists into the brain, 38 but such a route is unlikely to be used in clinical conditions. In addition, after acute central administration, AT 1 -receptor inhibition does not decrease the ACTH response to stress. 4, 9 Peripheral administration of AT 1 -antagonists without good access to brain AT 1 -receptors could not inhibit the central mechanisms of sympa-thetic control and the hypothalamic-pituitary axis response to stress. 39, 40 Additional advantages may be achieved when, as in our study, an insurmountable AT 1 -antagonist with good access to brain AT 1 -receptors is administered peripherally at low doses during a sustained period of time.
From our results, we conclude that peripheral treatment with an AT 1 -antagonist with access to central receptors is sufficient to almost completely eliminate the hormonal and sympathoadrenal response to stress. This indicates that AT 1 -receptor stimulation by Ang II plays a fundamental role in the response to acute stress. It appears that blockade of both peripheral and brain AT 1 -receptors may be more effective than peripheral or brain AT 1 -receptor blockade alone in blocking the stress response. We propose that compounds that readily and insurmountably block brain, as well as peripheral, AT 1receptors may be more therapeutically advantageous, not only for the treatment of hypertension but for the treatment of stress-related disorders.
